To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Biopharmaceutics Classification System
The Biopharmaceutics Classification System is a guidance for predicting the intestinal drug absorption provided by the U.S. Food and Drug Administration [1]. The fundamental basis for the BCS was established by Dr. Gordon Amidon who was presented with a Distinguished Science Award at the August 2006 International Pharmaceutical Federation (FIP) congress in Salvador, Brazil.[citation needed] Additional recommended knowledgeThis system allows to restrict the prediction using the parameters solubility and intestinal permeability. The solubility classification is based on a United States Pharmacopoeia (USP) apperature. The intestinal permeability classification is based on a comparison to the intravenous injection. All those factors are highly important, since 85% of the most sold drugs in the USA and Europe are orally administered. According to the Biopharmaceutics Classification System (BCS (disambiguation)), drug substances are classified as follows:
See also
References
Categories: Pharmacology | Pharmacy |
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Biopharmaceutics_Classification_System". A list of authors is available in Wikipedia. |